1. Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort study. Issue 6 (June 2019) Authors: Scott, Madeleine K D; Quinn, Katie; Li, Qin; Carroll, Robert; Warsinske, Hayley; Vallania, Francesco; Chen, Shirley; Carns, Mary A; Aren, Kathleen; Sun, Jiehuan; Koloms, Kimberly; Lee, Jungwha; Baral, Jessika; Kropski, Jonathan; Zhao, Hongyu; Herzog, Erica; Martinez, Fernando J; Moore, Bethany B;... Journal: Lancet Issue: Volume 7:Issue 6(2019) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mitochondrial antiviral signaling protein is crucial for the development of pulmonary fibrosis. Issue 4 (15th April 2021) Authors: Kim, Sang-Hun; Lee, Jung Yeon; Yoon, Chang Min; Shin, Hyeon Jun; Lee, Sei Won; Rosas, Ivan; Herzog, Erica; Dela Cruz, Charles S.; Kaminski, Naftali; Kang, Min-Jong Journal: European respiratory journal Issue: Volume 57:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗